DR. JOSHUA’S SCHIFFMAN’S CLINICAL TRIAL
We continue to donate money to MIB Agents for research and advocacy. Even before the Matthew Lehrman Osteosarcoma Fund existed, Matthew raised over $20,000 on Facebook to help battle this horrible disease that tragically took his life, but not his mission. This money helped to sponsor MIB Agents’ 2017 OutSmarting Osteosarcoma winner, Dr. Joshua Schiffman, whose clinical trial studies the p53 gene in elephants. This promising trial inspired the logo for our charity.